Novynette FC Tablets 0.02 mg/0.15 mg FC tablets
PDF Leaflet Revision Date: 19 April 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of pregnancy (oral contraception).
Dosage (summary)
One tablet daily for 21 days, followed by a 7-day tablet-free interval.
Special Populations
- Lactating women
- Women over 35
- Smokers
Pregnancy & Breastfeeding
Contraindicated during pregnancy; not advised during breastfeeding.
Key Drug Interactions
- Rifampicin
- Barbiturates
- Phenytoin
- St. John's Wort
Contraindications
- Hypersensitivity
- Pregnancy
- Liver impairment
- Thromboembolic disorders
Common side effects
- Nausea
- Headache
- Breast tenderness
- Mood changes
Counselling Points
- Take at the same time daily
- Use additional contraception if missed doses
- Report mood changes
Serious warnings
- Increased risk of thromboembolic events
- Monitor for depression
Important Disclaimer
The Novynette FC Tablets 0.02 mg/0.15 mg FC tablets professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
